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Michael J. Celestine, Jimmie L. Bullock, Shivani Boodram, Varma H. Rambaran*
and Alvin A. Holder*

Interesting properties of p-, d-, and f-block
elements when coordinated with dipicolinic
acid and its derivatives as ligands: their use as
inorganic pharmaceuticals
Abstract: This is a review of the literature concerning the
interesting properties of p-, d-, and f-block elements when
coordinated with 2,6-pyridinedicarboxylic acid (dipicolinic
acid, H2dipic) and its derivatives as ligands, with a focus on
their use as inorganic pharmaceuticals. Some of the complexes reported were used as insulin-like, bioimaging contrasting agents, antimicrobial agents, and anticancer agents.

et al. 2000, Muller et al. 2001, Hunag et al. 2003, Storm and
Luning 2003, Haino et al. 2005). It is a versatile, strong,
nitrogen-oxygen, multimodal donor ligand, which forms
stable complexes with diverse metal ions, sometimes in
unusual oxidation states (Renaud et al. 1997a,b, Jackson
et al. 2001, Devereux et al. 2002, Ouali et al. 2002, Kapoor
et al. 2005, Tse et al. 2006, Kirillova et al. 2007).

Keywords: bacteria; cancer; complexes; dipicolinic acid;
insulin.
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Introduction
The review focuses on the interesting properties of p-, d-,
and f-block elements when coordinated with 2,6-pyridine
dicarboxylic acid (dipicolinic acid, H2dipic) and its derivatives as ligands, with a focus on their use as inorganic
pharmaceuticals. 2,6-Pyridinedicarboxylic acid (dipicolinic acid, H2dipic), I, is a widely used building block in
coordination and supramolecular chemistry (Froidevaux
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The crystal structure of dipicolinic acid was first solved
by Takusagawa et al. (1973). Lately, the pharmacological
studies on dipicolinic acid have been given pertinent attention because of its low toxicity and amphophilic nature.
Dipicolinic acid is also present in natural systems as a
product of oxidative degradation of vitamins, coenzymes,
and alkaloids, to name a few (Siddiqi et al. 2010). Furthermore, it is constituent of fulvic acid, and is an intermediate
during l-tryptophan degradation as well as a precursor for
the NAD enzyme (Siddiqi et al. 2010). Dipicolinic acid and
its derivatives are now being featured as ligands in coordination complexes that have medicinal uses. The readers
are encouraged to read reviews and articles for information regarding the solution chemistry of dipicolinic acid,
its derivatives, and its coordination complexes (Buglyo
et al. 2005, Smee et al. 2009, Kirillov and Shul’pin 2013).
Please see the following review “Pyrazinecarboxylic acid
and analogs: Highly efficient co-catalysts in the metalcomplex-catalysed oxidation of organic compounds”
(Kirillov and Shul’pin 2013). In this report, the reviews and
featured articles have been published on the following
topics: antidiabetic effects of a series of vanadium dipicolinate complexes in rats with streptozotocin (STZ)-induced
diabetes (Willsky et al. 2011); how environment affects
drug activity: localization, compartmentalization, and
reactions of a vanadium insulin-enhancing compound,
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dipicolinatooxidovanadium(V) (Crans et al. 2011); and
metal speciation in health and medicine represented by
iron and vanadium (Crans et al. 2013).

Titanium
The chelate stabilization of a titanium(IV) (TiIV)-salan
alkoxide by ligand exchange with dipicolinic acid was
reported to form the redox inactive, heptacoordinate
complex 1. This was found to be stable in both silica gel
and aqueous media (Immel et al. 2012). The complex was
reported to be highly toxic toward cervix carcinoma, HeLa
S3, hepatocarcinoma, and Hep G2 cancer cell lines. It was
also found to have an enhanced antitumor efficacy in a
mouse cervical cancer model (Immel et al. 2012).
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1
The relative efficacy of complex 1 was compared to
another derivative in an in vivo model of cervical cancer;
18 C3 tumor-bearing mice received the complexes in a lowdose regime over multiple applications and their relative
tumor inhibitory effects were monitored. Impressively,
mice that were administered doses of complex 1 exhibited a significant reduction in tumor size. These data were
well received, although a reduction of tumor growth was
previously reported using a high-dose treatment with TiIV
halo-salan alkoxides. The dipic2- stabilized complex 1, in
contrast to the TiIV halo-salan alkoxides, was well tolerated and showed an improved efficacy at lower doses
(30 mg kg-1).

( d i a q u a ) ( 4-hyd rox y-2 ,6-p y r i d i n e d i c a r b ox yl a t o )
oxidovanadium(IV),
and
(4-amino-
2 ,6-pyridinedi
carboxylato)dioxidovanadium(V). The complex (4-hydroxy-
2,6-pyridinedicarboxylato)oxidovanadium(V)
was
investigated in greater detail with regard to the chemistry,
structure, kinetics, and insulin-like properties in rats with
STZ-induced diabetes (Crans et al. 2003a). An oral administration of [VO2(dipic-OH)]- was found to be effective in lowering both the hyperglycemia and hyperlipidemia of diabetes.
This was the first report concerning the effective lowering
of diabetic hyperlipidemia by a vanadium(V) (VV) coordination complex (Crans et al. 2003a).
Recently, there was a report of a new insulin-like
VV complex, the (4-hydroxypyridine-2,6-dicarboxylato)
oxovanadate(V) anion 2 (Crans et al. 2003b). The complex
was designed based on the desire to make a compound
with more favorable chemical and insulin-like properties than the analogous (pyridine-2,6-dicarboxylato)
oxovanadate(V) anion 3. The aqueous solution studies
were carried out on complex 2, where the complex was
found to be more stable at a neutral pH and had a different lability pattern than complex 3. The effect of
complexes 2 and 3 anions on various biological systems
including cell culture, yeast, and STZ-induced diabetic
rats were investigated. The growth of myoblast cells (L6)
was inhibited by both complexes 2 and 3 anions (Crans
et al. 2003b). Since the complexes have limited stability
at a neutral pH, yeast growth (pH range from 3.0 to 7.0)
was employed as an adjunct cell model. The effect of the
complex 3 anion on the inhibition of yeast cell growth
was found to be pH dependent. The authors reported that
these studies supported the hypothesis that the complex
2 anion would be more active as an insulin-like agent
because of its greater stability at a neutral pH (Crans
et al. 2003b). The studies involving the effect of complex
2 anion on hyperglycemia in rats with STZ-induced diabetes were also carried out. Complex 2 anion was found
to lower the diabetic hyperglycemia and joined the ranks
of the few VV complexes that have been shown to have
insulin-like properties in a diabetic animal model system
(Crans et al. 2003b).

Vanadium
For many years, it has been reported that vanadium-containing complexes have insulin-like properties both in vivo
and in vitro. The synthesis and characterization of new
vanadium complexes with insulin-like properties were
reported (Crans et al. 2003a). The three new complexes were
related to the (dipicolinato)dioxidovanadium(V) complex:
(4-hydroxy-2,6-pyridinedicarboxylato)dioxidovanadium(V),

The evaluation of the insulin-like character of a VV
complex in STZ-induced diabetic rats was investigated. The
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STZ-induced diabetic rats were orally administrated with
sodium
4-amino-2,6-dipicolinatodioxidovanadium(V)
dihydrate 4 (Li et al. 2009). The complex was administered through an aqueous solution at a concentration of 0.1 mg ml-1 for 20 days; then, the concentration
was increased to 0.3 mg ml-1 for the following 20 days.
At the end of the studies, sodium complex 4 statistically significantly reduced the levels of blood glucose
(p < 0.01), serum total cholesterol (p < 0.01), triglycerides
(p < 0.01), and the activities of serum aspartate amino
transferase (p < 0.05) and alkaline phosphatase (p < 0.01)
compared to untreated diabetic animals (Li et al. 2009).
After treatment with 0.3 mg ml-1 sodium complex 4, the
oral glucose tolerance was improved in diabetic animals
(p < 0.01). In addition, the daily intake of elemental
vanadium was markedly decreased in sodium 4-amino2,6-dipicolinatodioxidovanadium(V)
dihydrate-treated
diabetic rats compared to vanadyl sulfate-treated diabetic
rats, which suggested that the antidiabetic activity of the
element vanadium was elevated after being modified
with the coordinated organic ligand (Li et al. 2009). These
results suggested that sodium complex 4 was more effective than vanadyl sulfate at alleviating the symptoms of
diabetes (Li et al. 2009).

The aqueous vanadium(III) (VIII) speciation chemistry of two dipicolinate-containing complexes (where the
oxidation states of the vanadium metal center were +3,
+4, and +5) and the insulin-like effects were carried out
on a chronic animal model system (Buglyo et al. 2005).
The characterization of the VIII species was carried out
at a low ionic strength to reflect physiological conditions. It required an evaluation of the hydrolysis of VIII
at 0.20 m KCl. The aqueous VIII complexes with 2,6-pyridinedicarboxylic acid (H2dipic) and 4-hydroxy-2,6-pyridinedicarboxylic acid (H2dipic-OH) as ligands (where
the complexes and their systems were designated as VIIIdipic and VIII-dipic-OH) were characterized and the complexes were observed from pH 2 to 7 at 0.2 M KCl (Buglyo
et al. 2005). The VIII-dipic system formed stable 1:2 complexes, whereas the VIII-dipic-OH system formed stable
1:1 complexes. A comparison of these complexes with the
V-pic system demonstrated that a second ligand has a
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lower affinity for the VIII species, presumably reflecting
the bidentate coordination of the second dipic2- anion
to the VIII species. The thermodynamic stability of the
[VIII(dipic)2]- complex was compared to the stability of
the corresponding vanadium(IV) (VIV) and VV complexes.
Surprisingly, the VIII complexes were found to be more
stable than anticipated (Buglyo et al. 2005). An oral
administration of H[VIII(dipic)2(H2O)]·3H2O 5, [VIVO(dipic)
(H2O)2]·2H2O, and NH4[VVO2(dipic)], along with the positive control, VOSO4, significantly lowered diabetic hyperglycemia in rats with STZ-induced diabetes (Buglyo et al.
2005).

The STZ-induced diabetic rats treated with the VIIIand VIV-containing complexes had blood glucose levels
that were statistically different from those of the diabetic
group (Buglyo et al. 2005). The animals treated with the VV
complex had the lowest blood glucose levels of the treated
diabetic animals, which were statistically different from
those of the diabetic group at all time points. Among the
diabetic animals, the complexation to the dipicolinic acid
ligand increased the serum levels of vanadium after the
administration of the VV and VIV complexes but not after
the administration of the VIII complex when data are normalized to the ingested dose of vanadium (Buglyo et al.
2005). Due to the fact that the vanadium complexes with
different oxidation states have different biological properties, it was implied that redox processes must be important
factors for the biological action of vanadium-containing
complexes. The authors of these studies observed that
the VV complex was the most effective insulin-like agent,
in contrast to previous studies in which the VIV complex
with maltol as a ligand was the most effective. The authors
concluded that the effectiveness of coordinated vanadium
was both ligand and oxidation state dependent (Buglyo
et al. 2005).
Three vanadium complexes of chlorodipicolinic acid
(4-chloro-2,6-dipicolinic acid) in oxidation states (+3, +4,
and +5) were prepared and their properties were characterized across the various oxidation states. Additionally, the series of hydroxylamido, methylhydroxylamido,
dimethylhydroxylamido, and diethylhydroxylamido
complexes were prepared from the chlorodipicolinatodioxidovanadium(V) complex (Smee et al. 2009). The
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chemical properties of the chlorodipicolinate compounds are discussed and correlated with their insulinenhancing activity in STZ-induced diabetic Wistar rats
(Smee et al. 2009). The effect of the chlorosubstitution on
lowering diabetic hyperglycemia was evaluated and the
differences were found depending on the compounds’
oxidation state, as was similarly observed for the vanadium-containing-dipicolinate complexes (Buglyo et al.
2005). However, a linear correlation of oxidation states
with efficacy was not observed, which suggests that
the differences in the mode of action are not simply an
issue of redox equivalents. More importantly, the results
obtained contrasted the previous observation with the
vanadium-picolinate complexes, where the halogen substituents increased the insulin-enhancing properties of
the complex (Takino et al. 2001).

Manganese
A manganese complex, [Mn(dipic)2]·6H2O 6, was tested
for its antimicrobial activity (Tolga Çolak et al. 2009). In
in vitro antibacterial and antifungal activities, the complex
was tested with the use of the agar well diffusion method
by minimal inhibition concentration (MIC) (Tolga Çolak
et al. 2009). It was concluded that the complex was very
effective against Gram-positive bacteria and fungi but
ineffective against Gram-negative bacteria (Tolga Çolak
et al. 2009).
O
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In another report by Azadbakht et al., (H2dap)
[Co(dipic)2]·H2dipic·4H2O 9 (where dap = 3,4-diaminopyridine) was screened for its antimicrobial activities
against Bacillus cereus (ATCC 11778), Bacillus subtilis
(ATCC 12711), Staphylococcus aureus (ATCC 25923), Escherichia coli (ATCC 25922), and Pseudomonas aeruginosa
(ATCC 27853). However, the screening data revealed that
compound 9 exhibited only inhibitory results against
S. aureus (MIC > 14 mg cm-3). This finding was of great
interest because it seemed to show conflict toward the
well-known antimicrobial characteristic of the pure dipic
ligand toward a broad spectrum of bacteria (Chauvin et al.
2006, Gaillard et al. 2013).
The confirmation of this observation was done via a
comparison of independent data reported by Derikvand
et al. (2012), Siddiqi et al. (2010), and Soleimani (2011). It
is seen that the dipicolinic acid complexes show a varied
resistance to bacterial growth. These data were further
supported from the data retrieved from the antifungal
studies of Siddiqi et al. (2010) and also showed similar
inhibitory results for the complexes containing dipicolinic
acid as a ligand. It was therefore the general conclusion
from these results that showed the overall structure of the
tested compounds to be the principal factor influencing
the antimicrobial activity.

Cobalt
The syntheses of Co(II) and Co(III) dipicolinate complexes were reported via solid-state X-ray characterization of [Co(H2dipic)(dipic)]·3H2O 7 and [Co(dipic)(μ-dipic)
Co(H2O)5]·2H2O 8, respectively, in which two new coordination modes were observed (Yang et al. 2002). S
 olution
studies show a high stability of the Co(III) complex,
whereas the Co(II) complexes undergo pH-dependent
ligand exchange in the presence of excess ligand (Yang
et al. 2002). The [Co(dipic)2]2- anion was found to be effective in reducing the hyperlipidemia of diabetes using oral

Copper
Complexes 10 and 11 were tested for their ability to bind
to DNA, and it was seen that there was π-π stacking
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between the ligands of the complex and the base pairs
of DNA (Tabatabaee et al. 2013). A new Cu(II) complex,
[Cu(Hdipic)(H2dipic)]OH-·2H2O 12, was tested for its antimicrobial properties (Derikvand et al. 2012). Complex
12 was reported to have moderate inhibitory effects on
B. subtilis, B. cereus, and S. aureus but had no effect on
Gram-negative bacteria (Derikvand et al. 2012).

O
O
O
HO

OH

N
Cu
N

O

OH-•2H2O

O
OH

12

Zinc
The ternary complex formation of some potent insulinlike zinc(II) complexes of bidentate ligands, maltol and
3-hydroxy-1,2-dimethyl-pyridinone with (O,O), 2-picolinic
acid and 6-methylpicolinic acid with (N,O), and the tridentate dipicolinic acid with (O,N,O) coordination modes,
was studied in aqueous solutions by pH potentiometry
and spectroscopic [UV-visible, circular dichroism (CD),
and electrospray ionization-mass spectrometry (ESI-MS)]
methods in the presence of critical cell constituents such
as reduced l-glutathione (GSH) and adenosine 5′-triphosphate (ATP) (Enyedy et al. 2008). The results showed that
the formation of the ternary complexes was hindered in
the case of dipicolinic acid, especially with ATP, while it
was favored with the bidentate ligands in the physiological pH range (Enyedy et al. 2008). The driving force of the
formation of mixed-ligand species was found to be a more
enhanced coordination of GSH and ATP as second ligands
in the ternary complexes than in their binary ones due to
steric and electrostatic reasons. The mitochondrial dehydrogenase activity of the Zn(II) complexes, as an indirect
indicator for the glucose intake, was measured on Mono
Mac and 3T3-L1 adipocyte cell lines (Enyedy et al. 2008).
The activity of the complexes up to ∼10–100 μm concentration was in the range of the effect of 0.75–1.5 μm insulin,
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while at higher concentration it was broken down due to
the sensitivity of the cells and toxicity of the complexes
(Enyedy et al. 2008).
Two ternary Zn(II) complexes with 1,10-phenanthroline (phen) as the main ligand and a carboxylatecontaining ligand [dipicolinate (dipic2-) or l-threoninate
(l-Thr)] as the subsidiary ligand were prepared and characterized by elemental analysis, Fourier transform infrared (FTIR), UV-visible, fluorescence spectroscopy, X-ray
diffraction, molar conductivity, and electrospray ionization mass spectrometry (Chin et al. 2012). X-ray structure
analysis showed that both [Zn(phen)(dipic)(H2O)]·H2O
and [Zn(phen)(L-Thr)(H2O)Cl]·2H2O have octahedral
geometry about the Zn(II) metal center. Both complexes
were found to inhibit topoisomerase I and had better
anticancer activity than cisplatin against nasopharyngeal cancer cell lines HK1 and HONE-1 with concentrations causing 50% inhibition of cell proliferation (IC50
values) in the low micromolar range (Chin et al. 2012).
The complex [Zn(phen)(l-Thr)(H2O)Cl]·2H2O had the
highest therapeutic index for HK1 with a concentration
of 1.3 μm. Both Zn(II) complexes were found to induce
apoptosis. Changing the subsidiary ligand in the Zn(II)
complexes affected the UV fluorescence spectral properties of the coordinated phen ligand, the binding affinity
for some DNA sequences, nucleobase sequence selective
binding, the phase at which cell cycle progression was
arrested for treated cancer cells, and their therapeutic
index (Chin et al. 2012).

Gallium
Two gallium(III) complexes (13 and 14) have been synthesized with the first ligand being dipicolinic acid
and the second being either 2-picolinic acid or phen
(Kong and Sun 2009). The two gallium(III) complexes
were reported to have antimicrobial activities against S.
aureus, E. coli, and B. subtilis. The highest inhibitions
were reported against S. aureus for both complexes
when compared to the activity of the free ligands (Kong
and Sun 2009).
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Ruthenium
Ruthenium(II)-arene complexes of general formulas
[(η6-p-cymene)Ru(L1–3)Cl2] (where L1–3 = 3-acetylpyridine),
4-acetylpyridine,
and
2-amino-5-chloropyridine)),
correspondingly, [(η6-p-cymene)Ru(HL4,5)Cl2] (where
HL4 and HL5 are isonicotinic acid and nicotinic acid,
respectively), and [(η6-p-cymene)Ru(HL6–9)Cl] (where
H2L6–9 = 2,3-pyridinedicarboxylic acid, 2,4-pyridinedicarboxylic acid, 2,5-pyridinedicarboxylic acid, and
2,6-pyridinedicarboxylic acid), were prepared by the
reaction of [(η6-p-cymene)2RuCl2]2 with the corresponding ligand in 1:2 molar ratio in isopropanol (GrguricSipka et al. 2010). The complexes were characterized by
elemental analysis, mass spectrometry, IR and nuclear
magnetic resonance (NMR) spectroscopies, and X-ray
crystallography, where appropriate (Grguric-Sipka et al.
2010). The complexes revealed a low antiproliferative
activity in six investigated tumor cell lines (HeLa, B16,
FemX, MDA-MB-361, MDA-MB-453, and LS-174) (GrguricSipka et al. 2010).

stack with nucleobases and then enhance the complex
formation with DNA, which is the target in the chemotherapy of tumor. An example of such a heterocyclic
complex is [Pd(phen)(Hdipic-)]·4H2O 15, as reported by
Wang and Okabe (2005).

The interaction of [PdII(dipic)Cl]- with AMP, inosine-5′monophosphate (IMP), and reduced GSH was studied
kinetically as a function of [L] (L = AMP, IMP, GSH) and [Cl-]
and temperatures (10–35°C) at pH 4.0 (Chatterjee et al.
2005). It was seen that the [PdII(dipic)Cl]- anion complexes
first go through aquation replacing the chloride ligand
(Chatterjee et al. 2005). The aqua palladium(II) complexes
were reported to bind to weak nucleophiles such as AMP
and IMP (Chatterjee et al. 2005).

Rhodium
Several rhodium(II) complexes belonging to the general
structure [Rh(CO)2(dipic-L)] [where L = dithiocarbamate
(dtc) and xanthate derivatives] were synthesized and
assayed as cytostatic and antitumor agents in vitro
against KB cells and in vivo against P388 leukemia,
Ehrlich ascites carcinoma, sarcoma 180 ascites, and
ADJ/PC6A solid tumors. The assays against five Trypanosoma strains were also performed. Among the new
compounds, the [Rh(CO)2(dipic-dtc)] appeared to be
active in all biological systems without showing evident
nephrotoxicity (Sengupta et al. 1983, Craciunescu et al.
1991).

Palladium
The palladium(II) complexes have been highly sought
after in the realm of therapeutic anticancer drug development because of the similarities in bioactivities
and coordination behavior between palladium(II) and
platinum(II) complexes. Although the principle mechanism of its antitumor property is not yet known, it is confirmed that some species of the aromatic heterocycles can

Tin
A series of diorganotin dipicolinates were synthesized
and their antitumor activities against two human tumor
cell lines MCF-7, a mammary tumor, and WiDr, a colon carcinoma, were determined (Gielen et al. 1991, Costa et al.
2005). All complexes synthesized were only moderately
active in both cell lines tested. Among the series of synthesized complexes, n-Bu2Sn(2-O2C-C5H4N-3-OH)2 was the
most active of the series (ID50 values = 96 and 337 ng ml-1 in
MCF-7 and WiDr, respectively). All synthesized complexes
showed less activity compared to similar previously synthesized complexes, such as di-n-butyltin-bis(3-methoxysalicylate), as characterized by ID50 values of 44 and
82 ng ml-1 against MCF-7 and WiDr, respectively (Bouâlam
et al. 1991).

Yttrium
The highly selective separation of yttrium and lanthanides
is of interest for the design of radiopharmaceuticals for
the treatment of illness such as cancer and rheumatism,
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and in the past decade, much interest has been taken
in yttrium detection in biological applications (Horovitz 1999, Okamoto and Fukuzumi 2004). Chauvin et al.
(2006) have demonstrated that imprinting a polymer with
neutral [Y(16)3] [where 16 = 6-(4-vinylphenylcarbamoyl)
pyridine-2-carboxylic acid] complexes, followed by acid
demetallation, leads to resins highly selective for YIII and
heavy LnIII ions (Chauvin et al. 2006). The obtained ionimprinting effect stems from the rigid geometry imposed
by the three dipicolinate-based ligand strands, which are
maintained upon polymerization with styrene and divinylbenzene. The ion-imprinted polymer based on complex
16 was particularly efficient at extracting yttrium and has
a sizeable capacity (8.9 ± 0.2 mg g-1 resin) and a fast rate
of extraction (t1/2 = 1.7 min) (Chauvin et al. 2006). Complex
16 showed high selectivity for yttrium and lanthanide
cations when compared against alkali and alkaline earth
metals opening the potential for its use in the production
of highly pure 90Y and radiolanthanides for medicinal
application and for the trace analysis of radiochemicals in
food and the environment.
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4-triazolyl-DPAs have shown promising results under
two-photon excitation (TPE) and three-photon excitation
(THPE). The nanoparticles containing the lanthanide
complexes were obtained by a classic reverse emulsion
process involving tetraethyl orthosilicate (TEOS), NP-5
surfactant [polyoxyethylene (5) nonylphenyl ether], and
ammonia. The photophysical properties of NP-(17)3 to
NP-(20)3 showed two distinguishable types of NPs. No
significant luminescence was observed for NP-(17)3 and
NP-(18)3, indicating a poor incorporation of the rareearth complexes into the silica matrix. Conversely, the
complexes bearing the ammonium moieties [NP-Eu(19)3,
NP-Tb(19)3, and NP-Eu(20)3] were more easily embedded
into the silica nanoparticles, owning to their enhanced
capability to interact with the silica network, due to the
interactions between the ammonium moieties and the
deprotonated silanol groups. The treatment of NP-Eu(19)3NH2 with an excess of homobifunctional polyethylene
glycol (PEG) yielded luminescent PEGylated NPs NPEu(19)3-PEG-NHS. The presence of the -NHS termini on
the NP’s surface allows for the bioconjugation of these
nano-objects with biomolecules, potentially leading to
the applications of specified biolabeling and bioimaging
(Gaillard et al. 2013).

Lanthanides
Gaillard et al. (2013) have recently developed a “click”
approach to synthesize dipicolinic acid derivatives for
lanthanide chelates, which take advantage of the intrinsic
efficiency of the copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction. The simple dipicolinic acid
Na3Eu(17)3 and Na3Tb(17)3 complexes were used for the
comparison for Eu3+ and Tb3+ 4-triazolyl-DPA complexes
against Na3Eu(18)3, Na3Tb(18)3, Eu(19)3, Tb(19)3, Eu(20)3,
and Tb(20)3 bearing a hydroxymethyl, a chlorine, and a
trimethyl ammonium appendage, respectively. These

The functionalized tris-dipicolinate europium(III) complexes have been reported to show two-photon absorption
but exhibit weak stability in aqueous solutions due to the
ligand substitution by water molecules, which radically
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decreases the luminescence quantum yield and lifetime of
the complexes (Chauvin et al. 2004, Picot et al. 2008).
H2 o

2
[ Ln( DPA) 3 ] 3- 
 [ Ln( DPA)2 ( H 2O)x ] + DPA

Tris-dipicolinate europium complexes [Eu(dipic)3]3(21) where the dipicolinic acid was functionalized by
donor-π-conjugated moieties (Kong and Sun 2009, Grguric-Sipka et al. 2010), and further decorated with hydrosolubilizing PEG end-groups (22), were synthesized by
Picot et al. (2008). These novel europium complexes
fulfilled all of the requirements for use in biomedical
imaging application: (i) water solubility, (ii) intense emission, (iii) long luminescence lifetime, and (iv) significant
two-photon absorption. Philippot et al. (2011) utilized a
one-step method based on the spray drying of sol-gel solutions involving silicon alkoides as precursors of silica NPs
to incorporate and further stabilize similar lanthanide
complexes in aqueous media. The best water dispersion
and chemical stability of the Eu complexes embedded
in silica NPs were obtained using an 8TMOS+1BTTPOHD
silica matrix composition [where TMOS = tetramethoxysilane and BTTPOHD = 1,16-bis(trimethoxysilyl)-4,7,10,13tetraoxahexadecane]. Luminescence lifetimes remained
constant upon dilution and similar values were obtained
to those measured in the solid state, confirming the presence of nondissociated Eu complexes. High luminescent
intensity and good photostability were registered for NPs
slightly doped with Eu complexes (5 wt.%) by two-photon microscopy. The BTTPOHD moiety contained a PEG
moiety further increasing the biocompatibility of these
doped NPs, thus increasing the possibility of their potential application as stable biolabels for two-photon luminescence imaging (Philippot et al. 2011).

Platinum
Due to the success of cisplatin, there have been many
studies conducted on its derivatives to enhance carcinoma cell death while leaving the noncancerous cells
intact (Chatterjee et al. 2005). The complex [Pt(dipic)
Cl]- 23 was tested against breast (MCF-7), lung (NCIH460), and central nervous system (CNS) (SF-268) cancer
cells where the inhibition toward all three cell lines was
reported (Chatterjee et al. 2005). The growth inhibition of
50% of the cell populations was perceived as 0.57, 0.50,
and 0.70 mm for MCF-7, NCI-H460, and SF-268, respectively (Chatterjee et al. 2005). The efficacy of complex 23
was seen to be less than that of cisplatin (Chatterjee et al.
2005).
O

O

N
O

Pt

O

Cl

23

Bismuth
The incorporation of the acidic Bi(III) ion with ligands
bearing N-O donor atoms produced a wide selection of
pharmaceutically active complexes (e.g., complex 24),
which have been extensively used for the treatment
of a broad spectrum of gastrointestinal disorders. The
derivatives of dipicolinic acid have produced interesting
motifs that exhibit relatively good stabilities in aqueous
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environments and high solubilities in slightly acidic conditions (Anjaneyulu et al. 2010, 2011).

Conclusion
In conclusion, the complexes with dipicolinic acid and its
derivatives as ligands were reported to have effects that
ranged from antibacterial and anticancer agents to having
insulin-like properties. The different complexes were
reported to have the ability to inhibit the growth of Grampositive bacteria and fungi, to cause apoptosis in cancerous cells, to use as a bioimaging agent, or to reduce the
blood glucose levels in STZ-induced diabetic rats.
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